Location History:
- San Antonio, TX (US) (2021 - 2024)
- Washington, DC (US) (2024)
Company Filing History:
5 out of 5,444 
1 out of 1,587 
Years Active: 2021-2025
Title: Rong Li: Innovator in Cancer Treatment
Introduction
Rong Li is a prominent inventor based in San Antonio, TX (US). He has made significant contributions to the field of cancer research, particularly through his innovative patents. With a total of 5 patents, his work focuses on developing methods and compositions for detecting and treating various types of cancer.
Latest Patents
Among his latest patents, Rong Li has developed DDR1 antibodies and their uses. This patent relates to antibodies that bind to tumor discoidin domain receptor 1 (DDR1) and outlines their applications in detecting and treating cancer. Another notable patent involves methods of treating and preventing breast cancer with S-equol. This invention provides methods and compositions specifically designed for treating triple-negative breast cancer, which may be administered alone or in combination with other therapeutic compounds.
Career Highlights
Rong Li has worked with esteemed institutions such as the University of Texas System and Washington University. His career has been marked by a commitment to advancing cancer treatment through innovative research and development.
Collaborations
Rong Li has collaborated with notable colleagues, including Tyler Curiel and Bin Yuan. Their combined expertise has contributed to the advancement of cancer therapies and research.
Conclusion
Rong Li's contributions to cancer research through his patents and collaborations highlight his dedication to improving treatment options for patients. His innovative work continues to pave the way for advancements in the medical field.